Opinion|Videos|April 29, 2024

Observation Versus Treatment for Patients with CLL

Author(s)Rohit Gosain, MD, Rahul Gosain, MD, Nitin Jain, MD

Medical professionals discuss factors influencing the decision between observation and treatment, optimal diagnostic methods for chronic lymphocytic leukemia (CLL), and key markers to assess in patients with suspected CLL.

Episodes in this series

Rahul Gosain, MD; Nitin Jain, MD; and Rohit Gosain, MD, presenting slides

EP. 1 Observation Versus Treatment for Patients with CLL

Rahul Gosain, MD; Nitin Jain, MD; and Rohit Gosain, MD, presenting slides

EP. 2 Personalized Medicine: Optimizing Outcomes for Patients with CLL

Rahul Gosain, MD; Nitin Jain, MD; and Rohit Gosain, MD, presenting slides

EP. 3 Comparing BTK Inhibitors for Optimal CLL Treatment

Rahul Gosain, MD; Nitin Jain, MD; and Rohit Gosain, MD, presenting slides

EP. 4 Advancing CLL Treatment: Latest Updates and Strategies

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Related to this article

Acute Myeloid Leukemia | Image Credit: © LASZLO - stock.adobe.com.

November 6th, 2026

Tambiciclib Combo Shows Activity in Relapsed/Refractory Post-Venetoclax AML

Investigators will present detailed findings from a phase 2 study assessing a tambiciclib-based regimen in patients with relapsed/refractory AML at ASH 2026.

Trending on CancerNetwork

FDA Approves OncoMate MSI Dx as Pembrolizumab Companion Diagnostic in MSI-H Solid Tumors

FDA Approves Pimicotinib for Tenosynovial Giant Cell Tumors

Hyperthermic Mitomycin C Yields 68% 1-Year HG-RFS in BCG-Unresponsive NMIBC

Acylfulvene Prodrug LP-184 Shows Tolerability in Recurrent Glioblastoma

European Commission Expands Melflufen Label to Third-Line Multiple Myeloma